132 open real-world evidence positions
Merck & Co.
Amgen
Neurocrine Biosciences
Verona Pharma
REVOLUTION Medicines
Dyne Therapeutics
Vertex Pharmaceuticals
Viatris (2)
VaxCyte
Parexel
Regeneron
Axsome Therapeutics